CG
WST icon

Clinton Group’s West Pharmaceutical WST Stock Holding History

Clinton Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-13,835
Closed -$1.31M – 626
2017
Q2 		$1.31M Sell
13,835
-15,623
-53% -$1.44M 0.14% 243
2017
Q1 		$2.4M Buy
+29,458
New +$2.46M 0.14% 214
2016
Q3 		– Sell
-14,694
Closed -$1.11M – 1089
2016
Q2 		$1.11M Buy
+14,694
New +$1.07M 0.05% 447
2014
Q4 		– Sell
-5,220
Closed -$234K – 578
2014
Q3 		$234K Sell
5,220
-10,426
-67% -$443K 0.09% 309
2014
Q2 		$660K Sell
15,646
-477
-3% -$20.4K 0.33% 79
2014
Q1 		$710K Buy
+16,123
New +$759K 0.27% 90

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $18.8B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return